Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Breast Cancer Res Treat. 2012 Dec 16;137(2):10.1007/s10549-012-2373-1. doi: 10.1007/s10549-012-2373-1

Table 1.

Demographic data

Clinicopathologic parameter
Mean age at diagnosis (years) 63.5
Mean tumor size (mm) 30.7
n (%)
Tumor grade
    1 324 (23.1)
    2 576 (41.1)
    3 502 (35.8)
Tumor size
    pT1 385 (27.5)
    pT2 738 (52.6)
    pT3 107 (7.6)
    pT4 172 (12.3)
Lymph node stage
    pN0 725 (51.8)
    pN1 540 (38.6)
    pN2 134 (9.6)
Histological subtype
    Invasive ductal 993 (70.9)
    Invasive lobular 203 (14.5)
    Mucinous 38 (2.7)
    Apocrine 17 (1.2)
    Cribriform 41 (2.9)
    Papillary 19 (1.3)
    Medullary 45 (3.2)
    Other 44 (3.1)
Molecular subtype
    Luminal A (ER+ and/or PR+, HER2, Ki-67 < 14 %) 218 (15.6)
    Luminal B (HER2-negative) ER+ and/or PR+, HER2, Ki-67 ≥ 14 %) 683 (48.9)
    Luminal B (HER2-positive) (ER+ and/or PR+, HER2+) 156 (11.2)
    HER2 type (ER or PR, HER2+) 111 (7.9)
    Basal-like (ER,PR, HER2) 227 (16.2)